Skip to main content

Acumen Pharmaceuticals, Inc.

ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001576885

No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Acumen Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
81
+1 vs. Q1 2024
Shares held
43.6M
+215.1K (+0.5%) vs. Q1 2024
Total value
$105.5M
−$70.1M (−39.9%) vs. Q1 2024
New holders
23
22 more added
Sold out
22
19 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ABOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 81 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 41 institutionsQ4 2021: 52 institutionsQ1 2022: 57 institutionsQ2 2022: 47 institutionsQ3 2022: 50 institutionsQ4 2022: 60 institutionsQ1 2023: 62 institutionsQ2 2023: 53 institutionsQ3 2023: 66 institutionsQ4 2023: 67 institutionsQ1 2024: 80 institutionsQ2 2024: 81 institutionsQ3 2024: 73 institutionsQ4 2024: 80 institutionsQ1 2025: 81 institutionsQ2 2025: 71 institutionsQ3 2025: 69 institutionsQ4 2025: 71 institutionsQ1 2026: 84 institutionsQ2 2026: 96 institutions
Value heldQ2 2024: $105.5M
Q1 2021: $0Q2 2021: $0Q3 2021: $357.4MQ4 2021: $172.9MQ1 2022: $106.1MQ2 2022: $120.5MQ3 2022: $275.9MQ4 2022: $155.1MQ1 2023: $112.8MQ2 2023: $126.6MQ3 2023: $179.2MQ4 2023: $147.6MQ1 2024: $175.6MQ2 2024: $105.5MQ3 2024: $107.7MQ4 2024: $73.2MQ1 2025: $44.8MQ2 2025: $43.6MQ3 2025: $61.1MQ4 2025: $75.2MQ1 2026: $108.5MQ2 2026: $127.8M
Institutions holding ABOS and their total value by quarter
QuarterHoldersValue
Q2 202696$127.8M
Q1 202684$108.5M
Q4 202571$75.2M
Q3 202569$61.1M
Q2 202571$43.6M
Q1 202581$44.8M
Q4 202480$73.2M
Q3 202473$107.7M
Q2 202481$105.5M
Q1 202480$175.6M
Q4 202367$147.6M
Q3 202366$179.2M
Q2 202353$126.6M
Q1 202362$112.8M
Q4 202260$155.1M
Q3 202250$275.9M
Q2 202247$120.5M
Q1 202257$106.1M
Q4 202152$172.9M
Q3 202141$357.4M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Acumen Pharmaceuticals, Inc.; share changes are against Q1 2024.

Institutions holding ABOS in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Chicago Partners Investment Group LLC0$00.00%−13,958−100.0%Sold out
Integrated Wealth Concepts LLC0$00.00%−10,100−100.0%Sold out
Macquarie Group Ltd0$00.00%−1,247−100.0%Sold out